The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of the T-cell receptor landscape with survival in non-small cell lung cancer.
 
Alexandre Reuben
No Relationships to Disclose
 
Rachel Gittelman
Employment - Adaptive Biotechnologies
 
Jiexin Zhang
No Relationships to Disclose
 
Kelly Quek
No Relationships to Disclose
 
Luis M Vence
No Relationships to Disclose
 
Carmen Behrens
No Relationships to Disclose
 
Runzhe Chen
No Relationships to Disclose
 
Junya Fujimoto
Research Funding - Astellas Pharma
 
Chi-Wan Chow
No Relationships to Disclose
 
Xifeng Wu
No Relationships to Disclose
 
James Patrick Allison
Patents, Royalties, Other Intellectual Property - Inventor of a patent held by the University of California, Berkeley, and licensed to Bristol Meyers-Squibb; Inventor of a patent owned by Memorial Sloan-Kettering Cancer Center and licensed by Jounce Therapeutics
 
Padmanee Sharma
Stock and Other Ownership Interests - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics; Neon Therapeutics (I)
Consulting or Advisory Role - Amgen; Amgen (I); Astellas Pharma; AstraZeneca; AstraZeneca (I); BioAtla; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Constellation Pharmaceuticals; Constellation Pharmaceuticals (I); EMD Serono; EMD Serono (I); Evelo Therapeutics; Evelo Therapeutics (I); GlaxoSmithKline; GlaxoSmithKline (I); Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Merck Sharp & Dohme; Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Pieris Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)
 
Jianhua Zhang
No Relationships to Disclose
 
J. Jack Lee
No Relationships to Disclose
 
Boris Sepesi
No Relationships to Disclose
 
Don Lynn Gibbons
Consulting or Advisory Role - AstraZeneca
Research Funding - Janssen
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Andrew Futreal
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; HTG Molecular Diagnostics; Lilly; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Research Funding - Adaptimmune; EMD Serono; Genentech; HTG Molecular Diagnostics; MedImmune; Merck; Myriad Genetics; OncoPlex Diagnostics; Pfizer; Silicon Biosytems
 
Jianjun Zhang
No Relationships to Disclose